We are live on ! Find out more
ECU

Eisler Capital (US) Portfolio holdings

AUM $4.67B
1-Year Est. Return 35.2%
This Fund
S&P 500
This Quarter Est. Return
+11.68%
1 Year Est. Return
+35.2%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.03B
AUM Growth
+$863M
Cap. Flow
+$653M
Cap. Flow %
16.19%
Top 10 Hldgs %
39.5%
Holding
549
New
281
Increased
107
Reduced
120
Closed
29

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$17.4M
2
X
US Steel
X
+$10.1M
3
EBAY icon
eBay
EBAY
+$7.58M
4
HES
Hess
HES
+$6.17M
5
ACI icon
Albertsons Companies
ACI
+$6.08M

Top Sells

Rank Stock Value
1
PRFT
Perficient Inc
PRFT
+$5.42M
2
MU icon
Micron Technology
MU
+$4.14M
3
TSLA icon
Tesla
TSLA
+$2.29M
4
CVX icon
Chevron
CVX
+$2.17M
5
SBUX icon
Starbucks
SBUX
+$1.99M

Sector Composition

Rank Sector Weight
1 Technology 2.53%
2 Consumer Discretionary 1.21%
3 Communication Services 0.86%
4 Healthcare 0.7%
5 Energy 0.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VSAT icon
426
Viasat
VSAT
$11.6B
$716K 0.02%
+39,588
New +$831K
ZETA icon
427
Zeta Global
ZETA
$7.32B
$716K 0.02%
+65,521
New +$654K
PBH icon
428
Prestige Consumer Healthcare
PBH
$2.54B
$715K 0.02%
+9,860
New +$659K
MSGS icon
429
Madison Square Garden
MSGS
$9.47B
$715K 0.02%
+3,876
New +$720K
ALTR
430
DELISTED
Altair Engineering Inc
ALTR
$715K 0.02%
+8,301
New +$705K
TMDX icon
431
Transmedics
TMDX
$3.1B
$714K 0.02%
+9,662
New +$796K
CERE
432
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$714K 0.02%
+16,899
New +$710K
INCY icon
433
Incyte
INCY
$24.5B
$714K 0.02%
+12,537
New +$753K
RARE icon
434
Ultragenyx Pharmaceutical
RARE
$2.66B
$714K 0.02%
+15,296
New +$722K
PCVX icon
435
Vaxcyte
PCVX
$8.81B
$714K 0.02%
+10,454
New +$724K
SQSP
436
DELISTED
Squarespace, Inc.
SQSP
$714K 0.02%
+19,588
New +$636K
AMED
437
DELISTED
Amedisys
AMED
$714K 0.02%
+7,745
New +$726K
MCW
438
DELISTED
Mister Car Wash
MCW
$713K 0.02%
+92,049
New +$758K
CWT icon
439
California Water Service
CWT
$3.09B
$713K 0.02%
+15,345
New +$719K
IOSP icon
440
Innospec
IOSP
$2.31B
$713K 0.02%
+5,528
New +$671K
EXEL icon
441
Exelixis
EXEL
$12.7B
$712K 0.02%
+30,015
New +$667K
ALRM icon
442
Alarm.com
ALRM
$2.77B
$712K 0.02%
+9,819
New +$667K
FOLD
443
DELISTED
Amicus Therapeutics
FOLD
$711K 0.02%
+60,383
New +$772K
INSM icon
444
Insmed
INSM
$29B
$711K 0.02%
+26,213
New +$734K
BVN icon
445
Compañía de Minas Buenaventura
BVN
$8.84B
$710K 0.02%
+44,731
New +$697K
ZLAB icon
446
Zai Lab
ZLAB
$2.92B
$709K 0.02%
+44,234
New +$932K
DORM icon
447
Dorman Products
DORM
$3.95B
$709K 0.02%
+7,351
New +$633K
PTCT icon
448
PTC Therapeutics
PTCT
$6.15B
$708K 0.02%
+24,325
New +$681K
DNLI icon
449
Denali Therapeutics
DNLI
$3.95B
$708K 0.02%
+34,480
New +$648K
BKNG icon
450
Booking.com
BKNG
$160B
$707K 0.02%
+4,875
New +$695K

Similar funds

Eisler Capital (US)'s Q1 2024 Portfolio in Review

As of Q1 2024, Eisler Capital (US) held 549 positions worth $4.03B, up 27% from $3.17B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Eisler Capital (US) deployed $653M of net new capital in Q1 2024, opening 281 new positions and adding to 107 existing holdings. Its largest new stake was Amazon: 104,195 shares worth $18.8M.

By sector, the portfolio is most concentrated in Technology at 2.5% of assets, up from 1.1% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Perficient Inc, an estimated $5.42M trimmed.

  • Eisler Capital (US)'s largest Q1 2024 buy was Amazon: 104,195 shares worth $18.8M.
  • Eisler Capital (US) added most to Alphabet (Google) Class A in Q1 2024, an estimated $1.31M increase.
  • Eisler Capital (US)'s biggest Q1 2024 reduction was Perficient Inc, cutting an estimated $5.42M.
  • Eisler Capital (US) fully exited Starbucks in Q1 2024, selling an estimated $1.99M.
  • Eisler Capital (US)'s ten largest holdings make up 39% of its $4.03B portfolio in Q1 2024.
  • Eisler Capital (US) opened 281 new positions and closed 29 in Q1 2024.
  • Eisler Capital (US)'s portfolio value rose 27% quarter-over-quarter to $4.03B.

Based on Eisler Capital (US)'s 13F filing for Q1 2024, filed 14 May 2024.